Cannabis & Hemp Stocks Investment Tools – Schedule Demo Now!

Omni Health Progress Unknown on Plans to Open 
CBD Anti-Aging Clinic by December

Omni Health Progress Unknown on Plans to Open 
CBD Anti-Aging Clinic by DecemberMiami-based Omni Health (OTC:OMHE), a healthcare company developing cannabis-based pharmaceuticals and anti-aging products, announced plans last February 2018 to open a clinic in Miami by December 2018 focused on anti-aging and aesthetic treatments. However, no news has followed, leaving investors with no idea if progress is underway.

The company has 1.14 billion shares outstanding and a stock price currently at US$ 0.004.

Omni said last February that it would lease its first facility in South Miami. The facility would offer anti-aging regenerative medicine solutions. The following were among treatments to be available:

  • Bioidentical hormone therapy
  • Medical weight loss management
  • Nutrient supplements
  • Detoxification
  • I.V. Nutritional Therapy
  • Wellness coaching
  • Therapies for insomnia, migraines, and stress
  • Stem Cell Regeneration Treatments

The market research firm Global Industry Analysts estimated that a baby boomer-fueled consumer base “seeking to keep the dreaded signs of aging at bay” will push the US market for anti-aging products from $80 billion now to more than $114 billion by 2020.

Omni Health claimed last February that it plans to open the new facility in December 2018 with the goal of opening a network of clinics nationwide and becoming a leader in anti-aging medicine and integrative health management. Omni further claimed that it anticipates pro-forma annual revenue of $7,500,000 per clinic.

With no news from Omni, it is not surprising that the company’s stock price has steadily drifted down over the year.

Source Omni press release Feb 28, 2018

Omni Health Progress Unknown on Plans to Open 
CBD Anti-Aging Clinic by December

About Cannin Investment Group: Your Pot Stocks Experts

Cannin is your trusted resource for pot stocks. Our global team of experts evaluates all emerging pot stock investing opportunities. We aggregate hundreds of hours of research and provide tips on the best pot stock investments for 2020. 

Use Cannin as your resource for:

Is it too late to invest in pot stocks? No! This is the perfect time to invest.

Market analysts expect the legal cannabis industry will have an annual value exceeding $75 Billion in the next decade. The time to invest in pot stocks is now. Are you looking to buy stock in pot companies for 2020? Interested in emerging penny pot stocks? Looking for the best Canadian pot stocks to invest in? We can help.

Are you interested in pot stocks like Curaleaf, Trulieve, Aurora Cannabis, or Canopy Growth?

Predict price movements of pot stocks several hours in advance with our proprietary algorithmic stock trading software.

  • +25% Gains in 2020
  • +49.8% Gains in 2019
  • 108% Backtested since 2012

We’re so confident you’ll love our algotrading pot stock signals, we’re willing to give you a one-month risk-free trial to see it for yourself.

Profit from the best pot stocks – we’ll show you how at cannin.com.

Marijuana Stocks, Pot Stocks, Algorithmic Stock Trading, Best Hemp Stocks to Invest In